Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Early Treatment Intensification in Advanced-Stage High-Risk Hodgkin Lymphoma (HL) Patients, with a Positive FDG-PET Scan After Two ABVD Courses – First Interim Analysis of the GITIL/FIL HD0607 Clinical Trial

Blood (2012) 120 (21): 550.

https://doi.org/10.1182/blood.V120.21.550.550

Published: 2012

Journal Articles

Comparative Assessment of Different Criteria for Interim-PET Interpretation in a Cohort of Hodgkin Lymphoma Patients Treated in a Single Center.

Andrea Gallamini, MD, Stephane Chauvie, Francesca Fiore, MD, Roberto Sorasio, MD, Flavia Salvi, MD, Andrea Bianchi, MD, Alberto Biggi, MD

Blood (2009) 114 (22): 3657.

https://doi.org/10.1182/blood.V114.22.3657.3657

Published: 2009

Journal Articles

Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.

Michela Aluigi, PhD, Antonio Curti, MD, Emanuela Ottaviani, PhD, Giovanna Lucchetti, BS, Valentina Salvestrini, BS, Alessandra D’Addio, MD, Sara Trabanelli, BS, Francesca Fiore, MD, Massimo Massaia, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 4229.

https://doi.org/10.1182/blood.V110.11.4229.4229

Published: 2007

Journal Articles

Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.

Antonio Curti, MD, Valentina Salvestrini, BS, Michela Aluigi, PhD, Sara Trabanelli, BS, Emanuela Ottaviani, BS, Ilaria Durelli, BS, Alberto L. Horenstein, MD, Francesca Fiore, MD, Massimo Massaia, MD, Milena Piccioli, BS, Stefano Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 1345.

https://doi.org/10.1182/blood.V110.11.1345.1345

Published: 2007

Journal Articles

Risk of Hepatitis B and Efficacy of Treatment with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplant.

Luisa Giaccone, MD, Alfredo Marzano, MD, Isabel Resta, Andrea Marengo, Francesca Fiore, MD, Roberto Sorasio, MD, Moreno Festuccia, Mario Rizzetto, MD, Mario Boccadoro, MD

Blood (2007) 110 (11): 1970.

https://doi.org/10.1182/blood.V110.11.1970.1970

Published: 2007

Journal Articles

Acute Myeloid Leukemia-Derived Dendritic Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-dioxygenase.

Antonio Curti, MD, Simona Pandolfi, BS, Michela Aluigi, Phd, Elisa Ferri, Phd, Emanuela Ottaviani, BS, Ilaria Durelli, BS, Alberto L. Horenstein, MD, Francesca Fiore, MD, Massimo Massaia, MD, Milena Piccioli, BS, Stefano A. Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2006) 108 (11): 1899.

https://doi.org/10.1182/blood.V108.11.1899.1899

Published: 2006

Journal Articles

Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells.

Francesca Fiore, MD, Barbara Castella, Barbara Nuschak, Raffaello Bertieri, MD, Sara Mariani, Serena Zappia, Marta Coscia, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2006) 108 (11): 3893.

https://doi.org/10.1182/blood.V108.11.3893.3893

Published: 2006

Journal Articles

Leukemic Transformation Induces the Constitutive Expression of Indoleamine 2,3-Dyoxigenase Which Directly Increases CD4 + CD25 + T Regulatory Cells.

Antonio Curti, MD, Simona Pandolfi, BS, Michela Aluigi, BS, Barbara Valzasina, BS, Alessandro Isidori, MD, Elisa Ferri, BS, Sergio Rutella, MD, Ilaria Durelli, BS, Alberto L. Horenstein, MD, Francesca Fiore, MD, Massimo Massaia, MD, Milena Piccioli, BS, Emanuela Palmerini, MD, Stefano Pileri, MD, Mario P. Colombo, BS, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2005) 106 (11): 1210.

https://doi.org/10.1182/blood.V106.11.1210.1210

Published: 2005

NARROW

Early Treatment Intensification in Advanced-Stage High-Risk Hodgkin Lymphoma (HL) Patients, with a Positive FDG-PET Scan After Two ABVD Courses – First Interim Analysis of the GITIL/FIL HD0607 Clinical Trial

Comparative Assessment of Different Criteria for Interim-PET Interpretation in a Cohort of Hodgkin Lymphoma Patients Treated in a Single Center.

Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.

Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.

Risk of Hepatitis B and Efficacy of Treatment with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplant.

Acute Myeloid Leukemia-Derived Dendritic Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-dioxygenase.

Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells.

Leukemic Transformation Induces the Constitutive Expression of Indoleamine 2,3-Dyoxigenase Which Directly Increases CD4 + CD25 + T Regulatory Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only